Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
272.50    0.00 (0.00%)
Bid:
270.00
Ask:
275.00
Spread: 5.00 (1.852%)
Market Cap: £247.54m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Senior Management Appointments

26 Jun 2008 16:03

Concurrent Technologies Plc International Senior Management Appointments

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, is pleased to announce two senior management appointments for its subsidiaries in both the USA and India.

Mr. Brent Salgat is promoted to President of Concurrent Technologies Inc., the Company's US subsidiary and Mr. Manivannan Ramasamy has been appointed Managing Director of Concurrent Tech India Private Limited, the Company's Indian subsidiary.

Brent, a US citizen, joined Concurrent Technologies Inc in 2006 as Vice President of Sales and Marketing for North America. In this time he has led the expansion of the customer base in the region, demonstrating excellent results through his extensive knowledge of the market and network of contacts. Brent has an Electronics Degree from Michigan Technological University and has 20 years' experience in the embedded computer industry.

Manivannan, an Indian citizen, joined the group in late 2007 as a General Manager tasked with establishing an engineering design centre in Bangalore, India. He is a graduate of Anna University, India, with a Masters Degree in Applied Electronics. He has sixteen years' experience in the design of embedded products, predominantly in the telecommunications industry, working both in India and the US.

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

"I am delighted at these appointments; both Brent and Manivannan have demonstrated commitment, leadership and business skills which will continue to help strengthen the group and help drive further growth."

"The USA is a very important market for us, especially with our drive towards environmentally superior products targeted at the defence market. Brent's wealth of knowledge, energy and experience is strategically important to our expansion plans in North America."

"Manivannan's appointment coincides with the opening of our new design and development centre in Bangalore. We are very enthusiastic about India given the talent available to help expand our product lines more quickly, enabling an acceleration of our plans to break into new market areas. Manivannan is leading a growing team of skilled and dedicated engineers which complements the expanding product development programme being undertaken by our existing facility in the UK."

"The two appointments are a significant step forward for the Group."

26 June 2008 Contacts:Concurrent Technologies Plc 01206 752 626 Glen Fawcett, Managing Director Haggie Financial LLP 020 7417 8989 Nicholas Nelson/Kathy Boate Nominated Adviser Brewin Dolphin Investment Banking 0845 213 4212 Elizabeth Kennedy

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Note to Editors:

The Company develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the defence, security, telecommunications telemetry, scientific and aerospace markets. Using Intel‚® processors, including the latest Intel‚® Core¢â€ž¢ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

For more information on the Company and its products please visit http://www.cct.co.uk

vendor
Date   Source Headline
19th Mar 201412:36 pmRNSNotice of Results
17th Feb 20144:18 pmRNSHolding(s) in Company
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch
13th May 20134:25 pmRNSProduct Launch
24th Apr 20135:01 pmRNSDistribution of Annual Report and Accounts
9th Apr 20137:00 amRNSFinal Results
19th Mar 20134:25 pmRNSNotice of Results & Dividend
1st Mar 20132:15 pmRNSProduct Launch
24th Dec 20127:00 amRNSTrading Update
21st Dec 20121:17 pmRNSProduct Launch
21st Nov 20123:27 pmRNSHolding(s) in Company
5th Nov 201212:25 pmRNSProduct Launch
31st Oct 201210:32 amRNSTotal Voting Rights
19th Sep 20125:28 pmRNSHolding(s) in Company
5th Sep 20127:00 amRNSInterim Results
29th Aug 20125:36 pmRNSNotice of Results
22nd Jun 20124:42 pmRNSTotal Voting Rights
14th Jun 20123:50 pmRNSTransaction in Own Shares
7th Jun 20127:00 amRNSProduct Launch
31st May 20123:30 pmRNSTotal Voting Rights
29th May 20121:30 pmRNSAGM Statement
22nd May 201212:21 pmRNSTreasury Shares
8th May 20127:00 amRNSDistribution of Annual Report and Accounts
4th May 20123:53 pmRNSHolding(s) in Company
17th Apr 20123:51 pmRNSHolding(s) in Company
12th Apr 201211:44 amRNSHolding(s) in Company
26th Mar 20127:00 amRNSPreliminary Results
16th Mar 20123:17 pmRNSNotice of Results
6th Mar 20121:45 pmRNSDividend Declaration
16th Jan 20127:00 amRNSProduct Launch
29th Dec 20115:46 pmRNSDirector/PDMR Shareholding
22nd Dec 201112:41 pmRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.